58 studies found for:    "GW433908"[TREATMENT] AND HIV [CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
"GW433908"[TREATMENT] AND HIV [CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
2 Completed HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Conditions: Chronic HIV Infection;   HCV Coinfection
Intervention: Drug: Fosamprenavir
3 Active, not recruiting
Has Results
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GW433908;   Drug: ritonavir
4 Completed
Has Results
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Half-boosted Fosamprenavir;   Drug: Full Boosted Fosamprenavir
5 Completed
Has Results
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
6 Completed
Has Results
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Conditions: Infection, Human Immunodeficiency Virus I;   HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
7 Completed
Has Results
A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: fosamprenavir (GW433908);   Drug: ritonavir
8 Completed Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Intervention: Drug: No intervention; Observational study
9 Unknown  Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: GW433908
10 Completed Fosamprenavir Versus Other Protease Inhibitors
Conditions: Human Immunodeficiency Virus I Infection;   HIV Infection
Intervention: Drug: fosamprenavir
11 Completed Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
Condition: HIV Infections
Interventions: Drug: fosamprenavir/ritonavir;   Drug: olanzapine
12 Unknown  Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Nelfinavir mesylate;   Drug: Lamivudine;   Drug: GW433908
13 Unknown  Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Nelfinavir mesylate;   Drug: Lamivudine;   Drug: GW433908
14 No longer available Fosamprenavir Expanded Access
Condition: HIV Infection
Interventions: Drug: fosamprenavir;   Drug: Telzir®
15 Completed
Has Results
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Conditions: Hypertriglyceridemia;   HIV Infection
Interventions: Dietary Supplement: Lovaza;   Drug: fosamprenavir/ritonavir
16 Completed Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)
Condition: HIV Infections
Interventions: Drug: Fosamprenavir;   Drug: Saquinavir
17 Completed
Has Results
A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
Condition: HIV Infection
Interventions: Drug: ritonavir;   Drug: fosamprenavir
18 Completed A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
Condition: HIV
Interventions: Drug: fos-amprenavir calcium, ritonavir;   Drug: abacavir/lamivudine as Epzicom
19 Completed Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
Condition: HIV Infections
Interventions: Drug: fosamprenavir;   Drug: COMBIVIR;   Drug: ritonavir;   Drug: TRIZIVIR
20 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
Condition: HIV Infections
Interventions: Drug: lopinavir;   Drug: atazanavir;   Drug: efavirenz;   Drug: fosamprenavir;   Drug: darunavir;   Drug: tipranavir;   Drug: ritonavir;   Drug: nevirapine;   Drug: zidovudine;   Drug: lamivudine;   Drug: tenofovir;   Drug: emtricitabine;   Drug: abacavir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years